Boosters available for older teens The Centers for Disease Control and Prevention on Thursday signed off on booster shots of Pfizer's coronavirus vaccine for 16- and 17-year-olds who are six months past their second shot, clearing the way for vaccinations to start. The move comes amid a surge in infections nationwide due to the delta variant as well as uncertainty about the newly discovered omicron variant. "Although we don’t have all the answers on the Omicron variant, initial data suggests that COVID-19 boosters help broaden and strengthen the protection against Omicron and other variants. We know that COVID-19 vaccines are safe and effective, and I strongly encourage adolescents ages 16 and 17 to get their booster if they are at least 6 months post their initial Pfizer vaccination series," CDC Director Rochelle Walensky said in a statement. The CDC's announcement came just a few hours after the Food and Drug Administration (FDA) granted Pfizer an expansion of its emergency use authorization, to bolster protection against the delta and emerging omicron variant. "With both the delta and omicron variants continuing to spread, vaccination remains the best protection against COVID-19," acting FDA Commissioner Janet Woodcock said. No advisory panel: The FDA said the decision to authorize boosters for 16- and 17-year-olds was based on extrapolating the safety and efficacy data it already had for people aged 18 to 55, as well as some real-world data on vaccinations of teenagers. But the agency did not convene its outside expert advisory panel, which has previously raised questions about the risks of myocarditis and pericarditis — rare but serious cases of inflammation of the heart muscle and surrounding tissue, respectively — associated with the vaccine. The FDA said it felt the benefits outweighed the small amount of risk. Read more here. |
No comments:
Post a Comment